Related Experiment Video
Updated: Mar 7, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Relapsing Polychondritis Presented with Encephalitis Followed by Brain Atrophy
Suk-Won Ahn1, Moo-Seok Park1, Hae-Bong Jeong1
1Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul 06974, Korea.
Relapsing polychondritis (RP), a rare autoimmune disease, can unusually cause recurrent inflammatory brain lesions. This case highlights the complex neurological involvement in RP and its treatment.
Area of Science:
- Rheumatology
- Neurology
- Immunology
Background:
- Relapsing polychondritis (RP) is a rare systemic autoimmune disorder.
- RP involves inflammation and destruction of cartilaginous tissues.
- Neurological symptoms are rare complications of RP.
Observation:
- This report details an unusual recurrent case of inflammatory brain lesions in a patient with RP.
- The case focuses on clinical manifestations, autoimmune disease associations, and treatment responses.
- Neurological involvement in RP is not well understood.
Findings:
- The study describes a rare instance of recurrent inflammatory brain lesions in the context of relapsing polychondritis.
- Clinical presentation, autoimmune markers, and therapeutic outcomes were meticulously documented.
- The findings contribute to understanding the rare neurological manifestations of RP.
Implications:
- This case deepens the understanding of rare neurological complications in relapsing polychondritis.
- It underscores the importance of considering neurological involvement in RP patients.
- Further research is needed to elucidate the mechanisms and optimize treatment for RP-associated neurological conditions.
More Related Videos
09:41Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
Published on: January 20, 2023
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024